Global Health [MEDANTA] vs Krishna Institute of [KIMS] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Global Health Ltd. wins in 15 metrics, Krishna Institute of Medical Sciences Ltd. wins in 4 metrics, with 0 ties. Global Health Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Global Health Ltd. | Krishna Institute of Medical Sciences Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 58.23 | 91.01 | Global Health Ltd. |
| Price-to-Book Ratio | 8.08 | 12.01 | Global Health Ltd. |
| Debt-to-Equity Ratio | 25.47 | 123.72 | Global Health Ltd. |
| PEG Ratio | -1.74 | -2.27 | Global Health Ltd. |
| EV/EBITDA | 33.65 | 43.39 | Global Health Ltd. |
| Profit Margin (TTM) | 12.29% | 8.29% | Global Health Ltd. |
| Operating Margin (TTM) | 13.93% | 12.05% | Global Health Ltd. |
| EBITDA Margin (TTM) | 13.93% | 12.05% | Global Health Ltd. |
| Return on Equity | 14.21% | 15.90% | Krishna Institute of Medical Sciences Ltd. |
| Return on Assets (TTM) | 10.10% | 6.70% | Global Health Ltd. |
| Free Cash Flow (TTM) | $-241.56M | $-4.27B | Global Health Ltd. |
| Dividend Yield | 0.04% | N/A | N/A |
| 1-Year Return | 4.14% | 15.46% | Krishna Institute of Medical Sciences Ltd. |
| Price-to-Sales Ratio (TTM) | 7.15 | 7.52 | Global Health Ltd. |
| Enterprise Value | $295.72B | $306.34B | Krishna Institute of Medical Sciences Ltd. |
| EV/Revenue Ratio | 7.07 | 8.45 | Global Health Ltd. |
| Gross Profit Margin (TTM) | 77.19% | 80.26% | Krishna Institute of Medical Sciences Ltd. |
| Revenue per Share (TTM) | $156 | $91 | Global Health Ltd. |
| Earnings per Share (Diluted) | $19.12 | $7.49 | Global Health Ltd. |
| Beta (Stock Volatility) | -0.02 | 0.11 | Global Health Ltd. |
Global Health Ltd. vs Krishna Institute of Medical Sciences Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Global Health Ltd. | -1.23% | 0.78% | -1.82% | 17.21% | 6.24% | 2.35% |
| Krishna Institute of Medical Sciences Ltd. | -1.94% | -3.91% | 1.08% | 19.15% | 14.89% | 24.96% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Global Health Ltd. | 4.14% | 90.43% | 198.23% | 198.23% | 198.23% | 198.23% |
| Krishna Institute of Medical Sciences Ltd. | 15.46% | 140.42% | 285.51% | 285.51% | 285.51% | 285.51% |
Performance & Financial Health Analysis: Global Health Ltd. vs Krishna Institute of Medical Sciences Ltd.
| Metric | MEDANTA | KIMS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹298.62B | ₹262.07B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 163,931 | 498,054 |
| 90 Day Avg. Volume | 207,501 | 371,629 |
| Last Close | ₹1,219.90 | ₹769.85 |
| 52 Week Range | ₹956.00 - ₹1,456.50 | ₹575.80 - ₹811.00 |
| % from 52W High | -16.24% | -5.07% |
| All-Time High | ₹1,513.90 (Feb 12, 2024) | ₹811.00 (Jun 08, 2026) |
| % from All-Time High | -19.42% | -5.07% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.19% | 0.29% |
| Quarterly Earnings Growth | -0.34% | -0.40% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | 0.08% |
| Operating Margin (TTM) | 0.14% | 0.12% |
| Return on Equity (TTM) | 0.14% | 0.16% |
| Debt to Equity (MRQ) | 25.47 | 123.72 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹137.83 | ₹56.74 |
| Cash per Share (MRQ) | ₹45.46 | ₹3.00 |
| Operating Cash Flow (TTM) | ₹5.45B | ₹4.98B |
| Levered Free Cash Flow (TTM) | ₹4.81B | ₹3.85B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.04% | N/A |
| Last 12-Month Dividend | ₹0.50 | N/A |
Valuation & Enterprise Metrics Analysis: Global Health Ltd. vs Krishna Institute of Medical Sciences Ltd.
| Metric | MEDANTA (Apr 24, 2026) | KIMS (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 58.23 | 91.01 |
| Forward P/E | 43.09 | 53.92 |
| PEG Ratio | -1.74 | -2.27 |
| Price to Sales (TTM) | 7.15 | 7.52 |
| Price to Book (MRQ) | 8.08 | 12.01 |
| Market Capitalization | ||
| Market Capitalization | ₹298.62B | ₹262.07B |
| Enterprise Value | ₹295.72B | ₹306.34B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.07 | 8.45 |
| Enterprise to EBITDA | 33.65 | 43.39 |
| Risk & Other Metrics | ||
| Beta | -0.02 | 0.11 |
| Book Value per Share (MRQ) | ₹137.83 | ₹56.74 |
Financial Statements Comparison: Global Health Ltd. vs Krishna Institute of Medical Sciences Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | MEDANTA (2025) | KIMS (2025) |
|---|---|---|
| Revenue/Sales | 36.37B | 30.04B |
| Cost of Goods Sold | 8.80B | 11.26B |
| COGS % of Revenue | 24.2% | 37.5% |
| Gross Profit | 27.57B | 18.77B |
| Gross Margin | 75.8% | 62.5% |
| Research & Development | 4.14M | N/A |
| Operating Income (EBIT) | 7.37B | 6.16B |
| Operating Margin | 20.3% | 20.5% |
| EBITDA | 9.99B | 7.97B |
| EBITDA Margin | 27.5% | 26.5% |
| Pre-Tax Income | 6.47B | 5.58B |
| Pre-Tax Income % of Revenue | 17.8% | 18.6% |
| Income Tax | 1.66B | 1.43B |
| Income Tax % of Revenue | 4.6% | 4.8% |
| Net Income (Profit) | 4.81B | 4.15B |
| Profit Margin | 13.2% | 13.8% |
Balance Sheet & Liquidity Metrics
| Metric | MEDANTA (2025) | KIMS (2025) |
|---|---|---|
| Cash & Equivalents | 2.30B | 560.00M |
| Total Current Assets | 15.33B | 6.97B |
| Total Current Assets % of Revenue | 42.2% | 23.2% |
| Total Current Liabilities | 6.19B | 8.36B |
| Total Current Liabilities % of Revenue | 17.0% | 27.8% |
| Long-Term Debt | 6.24B | 22.87B |
| Long-Term Debt % of Revenue | 17.1% | 76.2% |
| Total Shareholders Equity | 33.88B | 24.19B |
| Retained Earnings | 22.48B | 10.35B |
| Retained Earnings % of Revenue | 61.8% | 34.5% |
| Property, Plant & Equipment | 15.13B | 11.47B |
Cash Flow Statement Comparison
| Metric | MEDANTA (2025) | KIMS (2025) |
|---|---|---|
| Operating Cash Flow | 5.45B | 4.98B |
| Operating Cash Flow % of Revenue | 15.0% | 16.6% |
| Capital Expenditures | -5.14B | -9.62B |
| Free Cash Flow | -241.56M | -4.27B |
| FCF Margin | -0.7% | -14.2% |
| Debt Repayment | -1.83B | -837.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MEDANTA | KIMS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 268.70M | 400.14M |
| Float Shares | 87.05M | 232.50M |
| % Held by Insiders | 67.51% | 43.35% |
| % Held by Institutions | 21.68% | 40.36% |
| % Held by Public | 10.81% | 16.29% |
Dividend Analysis & Yield Comparison: Global Health Ltd. vs Krishna Institute of Medical Sciences Ltd.
| Metric | MEDANTA | KIMS |
|---|---|---|
| Last 12-Month Dividend | ₹0.50 | N/A |
| Last 12-Month Dividend Yield | 0.04% | N/A |
| 3-Year Avg Annual Dividend | ₹0.17 | N/A |
| 3-Year Avg Dividend Yield | 0.04% | N/A |
| 3-Year Total Dividends | ₹0.50 | N/A |
| Ex-Dividend Date | Aug 22, 2025 | N/A |